Skip to content

Mahmoud Abdelaziz

NPI 1750814562ActiveIndividual· Internal Medicine· Manhasset, NY

Internal Medicine in Manhasset, New York, trained at New York College of Osteo Medicine of New York Institute of Technology (class of 2017). Part D covered 97 prescriptions written in 2024, 73% of them generic. Otsuka Pharmaceutical Development & Commercialization, Inc. reported $125.00 in payments in 2025, mostly food and beverage.

Overview

NPI1750814562
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedApr 7, 2017
Last updated in NPPESNov 20, 2023
Certified by providerNov 20, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X322626NY
Internal Medicine207R00000X34.016188OH

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nephrology (NY)

Part D prescriptions in 2024

Prescriptions (claims)97 · 208 30-day fills
Patients48
Total drug cost$22,661
Generic share73% of claims

Medicare sources and data years

Education and affiliations

Medical schoolNew York College of Osteo Medicine of New York Institute of Technology
Graduation year2017
Medicare specialtyNephrology

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$125.00 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$125.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Manhasset

All Internal Medicine providers in New York →